Cited by 81Adrenal and Paraganglionic TumorsAdrenal Hormones and DisordersPituitary Gland Disorders and Treatments

Recurrent or Metastatic Disease in Select Patients With Adrenocortical Carcinoma: Aggressive Resection vs Chemotherapy

Jensen, J. Christian·1991·Archives of Surgery

Abstract

In a retrospective, nonrandomized comparison of patients with first recurrence of adrenocortical cancer, 18 patients were treated with chemotherapy (primarily mitotane) and 15 patients were treated with surgical resection plus similar chemotherapy. Surgical resection of recurrent adrenocortical cancer was often extensive, with morbidity in 20% of patients and no mortality. Mitotane therapy was ineffective at controlling tumor growth. Median survival from the time of diagnosis for all patients was only 23 months and no patient was cured. Disease-free interval greater than 12 months was associated with prolonged survival, but it only occurred in six patients (18%), with a similar frequency in both treatment groups. Surgical resection of recurrent disease was associated with prolonged survival from the time of first recurrence. The potential benefit of this resection was evident in the 5 patients (33%) who were able to live greater than 5 years from the time of first recurrence with improvement in symptoms and signs of hypercortisolism. Although no patient with recurrent adrenal cancer could be cured, resection of recurrent disease was associated with a slight prolongation of survival and good palliation of Cushing's syndrome.

Integrity signals

Registry

Crossref · 10.1001/archsurg.1991.01410280059008

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tumor grade and additional nonsurgical treatment influence outcome, although subsequent recurrence is expected.

    “data from other studies note their influence on outcome, although subsequent recurrence is expected (267, 268).”

    From Adrenocortical carcinoma (2014) · cites this paper as [268]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jensen, J. C.
Affiliations
National Institutes of Health (US)
Corresponding author
Jensen, J. Christian
Venue
Archives of Surgery
Published
1991-04-01
Volume
126
Issue
4
Pages
457
ISSN
0004-0010 (ISSN-L)
OpenAlex
W2164470094
Cited by
81
References
24
Citations by year
2026: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 6 · 2014: 2 · 2013: 1 · 2012: 2
FWCI
1.51
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
adrenocortical carcinoma, metastatic adrenal cancer, mitotane, chemotherapy, surgical resection, survival, disease-free interval, Cushing's syndrome, hypercortisolism, palliative care
MeSH terms
Adolescent, Adrenal Cortex Neoplasms, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Cushing Syndrome, Humans, Middle Aged, Mitotane, Neoplasm Metastasis, Neoplasm Recurrence, Local, Palliative Care, Prognosis, Retrospective Studies, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review